Laura Brege - Director at Acadia Pharmaceuticals Inc

Insider Transactions and Holdings

Entity Type
Individual
Role
Director
Stock Symbol
ACAD on Nasdaq
All Insider Reports
All Insider Reports

Laura Brege - trading volume in the past year for Acadia Pharmaceuticals Inc

Holdings reported by Laura Brege for Acadia Pharmaceuticals Inc

Security Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
Common Stock 15.1K $329K $21.78 Jun 4, 2025 Direct
Restricted Stock Units 8.11K $159K $16.94 May 29, 2025 Direct Common Stock
Director Stock Options (Right to Buy) 13.8K May 29, 2025 Direct Common Stock

Transactions reported by Laura Brege for Acadia Pharmaceuticals Inc

Sym Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.